Cannabinoid receptor ligands: Clinical and neuropharmacological considerations relevant to future drug discovery and development

Expert Opinion on Investigational Drugs

Volumn 5, Issue 10, 1996, Pages 1245-1253

  Pertwee, R G ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CANNABINOL; DRONABINOL; GUANINE NUCLEOTIDE BINDING PROTEIN; RADIOLIGAND; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

AUTONOMIC NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM; DRUG INDICATION; DRUG RECEPTOR BINDING; DRUG RESEARCH; DRUG SELECTIVITY; EDITORIAL; HUMAN; IMMUNE SYSTEM; NEUROPHARMACOLOGY; NONHUMAN; RECEPTOR AFFINITY;

EID: 0029807177     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.5.10.1245     Document Type: Editorial

References (0)